23rd EURETINA Congress
Oct 5 - Oct 8, 2023
Friday, Oct. 6th, 12:42-12:47pm CET
A 12-week Phase 2/3 Double-masked, Randomized, Multicenter Study of OCS-01 OPTIREACH® Technology Topical Dexamethasone Eye Drops in Subjects with Diabetic Macular Edema (DME): Efficacy and Safety Findings.Presented by Prof. Ramin Tadayoni, M.D.
Presented in Euretina Session 6: Landmarks & Late Breakings held from 12:15 to 13:15pm CET